Open Orphan Share Discussion Threads

[m5] 13/6/2022 22:26

LOL! That's true.

[m5] 13/6/2022 16:36

To be fair, in this market malaise, we aint done too bad today.

[ironman22] 13/6/2022 15:50

Their is no 'one big seller' just multiple sellers dumping riskier stocks like OO in these troubled times.

[jeanesy] 13/6/2022 13:48

MO probably knows someone is still selling big time and is biding his time. The markets are dire right now. Tin hats time for those not wanting to protect their capital !!

[digger2779] 13/6/2022 11:19

Looks like we are on to a hiding for nothing now the yanks money printing has come home to roost.

[m5] 13/6/2022 10:40

Bonkers, but a hell of a time for MO to buy and I would not be surprised to see CF adding a few.

[marvelman] 13/6/2022 09:46

Blimey...78 million market cap and 15 million cash. On any metric this is now a gift for new investors.

[gregb] 13/6/2022 09:21

Fabulous top up / average down price! Good luck to all those in a position to do so.

[jeanesy] 13/6/2022 08:14

The relentless selling continues ! About to reach 2 year lows here

[elrico] 12/6/2022 21:15

masergt,

In your eagerness to spin your little web of deceit, you have confused yourself or perhaps do not understand your argument?

"The infectious disease clinical trial market is projected to reach over $5.5 billion by 2027 due to the rapid increase of infectious diseases market globally."


Citing Global Market Insights, yet in the AR, he says, "the lasting legacy of the pandemic is a significantly enlarged infectious and respiratory disease market, which is expected to grow to in excess of $250bn by 2025.

They are a different market - meaning not the same, alternative revenues stream, etc., etc.!!

The nonsense about the impact of losing a client and the negative impact! I guess it escaped your notice that ORPH group of Companies has four of the top ten big pharma as clients.

There were over sixty clients in 2021, and 80% were repeat business.

You also seem confused about the £3.8 million additional cash burn in 2021. This is easily explained as one-off costs associated with the capital reduction last June, plus Poolbeg associated fees, CAPEX and building maintenance and new equipment for the facilities' timing of cash receipts.

Contracts take several months, not days. If you don't understand how negotiations work or what is involved, I respectfully suggest you have your pennies over to a fund manager like Mr Woodford. There is also a small matter of designing a trial/study; for example, A clinical trial design must define the main criteria: type of study (including duration and randomization of volunteers in assigning them either the treatment or the control), patient population, exclusion and inclusion of a volunteer in the clinical trial, safety, and efficacy endpoints, which need to be agreed by all.

At least this clown, paid or not, has a better grasp of the business.

Take care, back in a few weeks.

[sikhthetech] 12/6/2022 20:35

Here's one for the gang:


From the results:

Which entity do you shareholders have shares in? It's not the parent company which made a £1.5m loss, is it? Where's the income statement account for the parent company?




"The Company has elected to take the exemption under section 408 of the Companies Act 2006 not to present the parent Company income statement account. The loss for the parent Company for the year was £1,522,000 (2020: loss of £1,891,000)."

[m5] 12/6/2022 16:40

I don’t disagree with much of what you have said. We responded to the information we were given. I have been vocal with regards to CF and what I believe was his irresponsible comments.MO is now at the helm, under promise and over deliver I hope!! Anyway we all have a choice, sell, hold or buy more and ultimately we are responsible for our own actions. I am disappointed as anyone but there is still a lot to look forward to. Time will tell.

[m5] 12/6/2022 12:39

masergt
11 Jun '22 - 18:37 - 3968 of 3972

I don't shoot the messenger. If you think that sikhthetech posting style is acceptable fair enough. As with everything there are ways and means of doing things and getting a point across in a reasnoble way. Constantly saying the same things is pointless and irritating and defeats the object, and adds little credibility, just to me confirms an agenda.Of course we have alot of negativity right now, but you would think that we are going bust from the sentiment. I am far from happy with the share price and aspects of CF's tenure, but its been done to death. When we have such an overreaction it is usually a bloody good signal that we are approaching a buy area. No advice to anyone, just my observations.

[davew28] 12/6/2022 09:02

Masergt, followed by 12toes. Says it all. Filter bin.

[supernumerary] 11/6/2022 23:26

'I could go on'

You will, Oscar, you will...

[digger2779] 11/6/2022 13:00

KPE - I hope not. However, the selling has to stop some time? It's been pretty relentless and I'm just hoping someone is building a stake which they intend to keep long term. These 100k sells seems to me that CF's "chummy" ex director has started his summer unload.
Let's hope we don't get another positive RNS any time soon.

[m5] 10/6/2022 16:30

What bloody gang, most of us are well underwater. You are also new to the BB, so you know FA.

[sikhthetech] 10/6/2022 16:12

Pointless blaming CF. It has been known for months that he is overpromising and underdelivering, the questionable corporate structure.

The point is this was pumped and dumped with the gang deliberating trying to distract any gullible PIs away from the red flags...